Safety and Immunogenicity of Prime-Boost Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-002)
Clinical trial NCT02280408 · COMPLETED
Trial details
- NCT number
- NCT02280408
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-07
- Primary completion
- 2015-12-10
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.